Strides Pharma Science Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

2,153.26

1,854.50

1,979.00

1,857.57

1,674.15

Operating profit

255.28

98.48

76.63

187.32

210.04

Interest

167.93

138.68

74.24

65.34

66.71

Gross profit

159.65

43.86

125.87

210.98

243.49

EPS (Rs)

7.13

0.52

20.07

8.72

12.47

Other income

72.31

84.07

123.49

89.00

100.16

Stock adjustment

4.62

21.04

114.26

-117.53

1.18

Raw material

1,072.63

1,020.10

935.42

1,050.10

848.34

Power and fuel

-

-

-

-

-

Employee expenses

335.21

267.01

272.09

272.72

221.77

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

485.53

447.87

580.60

464.96

392.82

Provisions made

-

-

-

-

-

Depreciation

84.67

93.62

104.37

99.34

91.63

Taxation

4.13

-69.44

-158.68

33.40

40.16

Net profit / loss

65.49

4.68

180.19

78.24

111.70

Extra ordinary item

-5.37

-15.00

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

91.90

90.30

89.79

89.68

89.55

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

11.86

5.31

3.87

10.08

12.55

GPM (%)

7.17

2.26

5.99

10.84

13.72

NPM (%)

2.94

0.24

8.57

4.02

6.30